reference/24208303

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/24208303

Outgoing Links

Predicate	Object
contentType	Comparative Study\|Journal Article\|Multicenter Study\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't
endingPage	1854
issn	0735-1097
issueIdentifier	18
pageRange	1844-1854
publicationName	Journal of the American College of Cardiology
startingPage	1844
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_91e0f50771a78823b073fbac673c0f27 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_c8d7e023c61c6a60f68785a2d0c3948a http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_9b6ad752664cbcbae6c832e084a886a3 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_f65bdcf22d45958293b832d59412e244
bibliographicCitation	Park KW, Chae IH, Lim DS, Han KR, Yang HM, Lee HY, Kang HJ, Koo BK, Ahn T, Yoon JH, Jeong MH, Hong TJ, Chung WY, Jo SH, Choi YJ, Hur SH, Kwon HM, Jeon DW, Kim BO, Park SH, Lee NH, Jeon HK, Gwon HC, Jang YS, Kim HS. Everolimus-eluting versus sirolimus-eluting stents in patients undergoing percutaneous coronary intervention: the EXCELLENT (Efficacy of Xience/Promus Versus Cypher to Reduce Late Loss After Stenting) randomized trial. J Am Coll Cardiol. 2011 Oct 25;58(18):1844–54. doi: 10.1016/j.jacc.2011.07.031. PMID: 22018294.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cbf9071096ea3199ef0295441f0510f5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7651090a66b3d7057b671d0394ea265b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_58a884b8fcbdf14ed4ac33de8a6b1f85 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6f1e0b68e341dd74d5b5ddd2cb4670f3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_83f0caa7cb00af6ad496fddc2b1fd08c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cc0ff82edd7a025c73dafd91bba9a7bf http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-3895-1915 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6effd2a8b0b874ec184eca33e3f143f2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b597035a84ed1ac7d3f4706e18d03583 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_01dce67dc43ed78c25ec8f6e3f835d53 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5988ddc30a3cbcb8420ebecb1ddfba74 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_be1b8bbaa98aa865e18da03f0aa82409 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d86f52034dbdaf87a29029dd544b4d95 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3107ddd47d3d902021dcca82b16466e6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-3500-1746 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9b98675c3802fdd0732840d6a22a0fea http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_083af8bb7128ff48665e702b9a953012 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_82fc155b6e79b2cf7229e82904da20cc http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8565fcecf7183936b02cc2a05bed4086 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0dd84958fa7b4f7c0f507ebbb6be079e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_35035af83c1ccbd26de15461ab56b2a9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a8edf072a2e77851eb580b1808fa6cbe http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b6f6608235bb9a4abba6e4f188119ec3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-9521-4102 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a4fe90fe0439fd07985f0f28e17a92c1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5c6e395afc111c0b94c26610440db5b2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_33ffe37c19ca70a5142cf91d96a8bb78 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1b6ad64a037c94fed06c6526be10f8ec
date	2011-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/22018294 https://doi.org/10.1016/j.jacc.2011.07.031
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/4429 https://portal.issn.org/resource/ISSN/0735-1097
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Everolimus-eluting versus sirolimus-eluting stents in patients undergoing percutaneous coronary intervention: the EXCELLENT (Efficacy of Xience/Promus Versus Cypher to Reduce Late Loss After Stenting) randomized trial
discusses	http://id.nlm.nih.gov/mesh/M0011171 http://id.nlm.nih.gov/mesh/M0029863 http://id.nlm.nih.gov/mesh/M000602394
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D015906 http://id.nlm.nih.gov/mesh/D020123Q000031 http://id.nlm.nih.gov/mesh/D020123Q000008 http://id.nlm.nih.gov/mesh/D054855 http://id.nlm.nih.gov/mesh/D007166Q000008
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D000068338 http://id.nlm.nih.gov/mesh/D011446 http://id.nlm.nih.gov/mesh/D017023 http://id.nlm.nih.gov/mesh/D023903Q000453 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D011475 http://id.nlm.nih.gov/mesh/D003327Q000628
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8564 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284616 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6442177 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID36314 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9412

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID248766214 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID242749350

Total number of triples: 74.